PGR and breast cancer: The in silico analysis of the signaling pathways that could be associated with the differentially expressed genes was performed using MetaCore software (Clarivate Analytics, USA), and it revealed that the main pathway related to NRIP1 silencing was “PR action in breast cancer-stimulation of cell growth and proliferation” (Fig. 8).